FFAR2 and chronic kidney disease: Butyrate positively impacts kidney function by suppressing inflammation through kidney butyrate-GPR43 signaling.50 A recent study found lower plasma and fecal SCFA levels in CKD patients,51 and we confirmed reduced basal butyrate levels in CKD patients feces.